APA (7th ed.) Citation

Clarke, C. S., Hunter, R. M., Gabrio, A., Brawley, C. D., Ingleby, F. C., Dearnaley, D. P., . . . James, N. D. Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Clarke, Caroline S., et al. Cost-utility Analysis of Adding Abiraterone Acetate Plus Prednisone/prednisolone to Long-term Hormone Therapy in Newly Diagnosed Advanced Prostate Cancer in England: Lifetime Decision Model Based on STAMPEDE Trial Data. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Clarke, Caroline S., et al. Cost-utility Analysis of Adding Abiraterone Acetate Plus Prednisone/prednisolone to Long-term Hormone Therapy in Newly Diagnosed Advanced Prostate Cancer in England: Lifetime Decision Model Based on STAMPEDE Trial Data. Public Library of Science (PLoS).